Diabetes and obesity drugs linked to thyroid cancer

The European Medicines Agency (EMA), the European Union's (EU) version of the Food and Drug Administration (FDA), issued a drug safety signal this week about the elevated thyroid cancer risk associated with certain classes of pharmaceuticals for Type 2 diabetes and obesity. Semaglutide, the active ingredient found in the widely used anti-diabetes and anti-obesity drugs Ozempic and … Continue reading Diabetes and obesity drugs linked to thyroid cancer

Thyroid Cancer & Iodine

Medical ignorance is epidemic and nowhere is this more evident than in how contemporary medicine views and treats thyroid cancer. Overtreatment of thyroid cancer with radioactive iodine is rampant even though there is substantial uncertainty about the indications for radioactive iodine for thyroid cancer. Radioactive iodine absorbed by the thyroid can injure the gland. There was a large increase … Continue reading Thyroid Cancer & Iodine